Trials / Conditions / Renal Cell Carcinoma Metastatic

Renal Cell Carcinoma Metastatic

18 registered clinical trials studyying Renal Cell Carcinoma Metastatic — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic NCT07292168	Kidney Cancer Research Bureau	Phase 1 / Phase 2
Recruiting	Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study NCT06726421	Sun Yat-sen University	Phase 3
Recruiting	A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma NCT06321250	Jemincare	Phase 1
Completed	Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy NCT06161233	Istituti Clinici Scientifici Maugeri SpA	N/A
Recruiting	Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Mana NCT06995664	Royal Marsden NHS Foundation Trust	N/A
Recruiting	A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (R NCT05548621	St. Antonius Hospital	—
Terminated	Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma NCT05103722	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	N/A
Unknown	A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanc NCT04764487	Weprom	Phase 3
Recruiting	TDM for Optimized Outcome in Patients With mRCC. NCT04659343	Niels Fristrup	—
Recruiting	Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial NCT03977571	Niels Fristrup	N/A
Terminated	A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma NCT03905889	Brown University	Phase 1
Terminated	High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal NCT03991130	Gregory Daniels	Phase 2
Terminated	Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma NCT03562507	University of Michigan Rogel Cancer Center	Phase 2
Completed	Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC NCT03699579	Ipsen	—
Terminated	Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells NCT06377722	Fundacion Oncosur	Phase 2
Terminated	Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or NCT03013946	AIO-Studien-gGmbH	Phase 3
Active Not Recruiting	A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) NCT02974738	Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 1
Completed	Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post NCT02432846	Mendus	Phase 2